WA
NVO

WPG Advisers’s Novo Nordisk NVO Stock Holding History

WPG Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76K Buy
1,585
+1,168
+280% +$50.2K 0.04% 229
2026
Q1 		$15.3K Sell
417
-1,130
-73% -$53.5K 0.01% 555
2025
Q4 		$78.7K Sell
1,547
-310
-17% -$15.9K 0.06% 208
2025
Q3 		$103K Sell
1,857
-228
-11% -$13.3K 0.08% 153
2025
Q2 		$144K Sell
2,085
-1,165
-36% -$79.2K 0.12% 115
2025
Q1 		$226K Sell
3,250
-825
-20% -$68.1K 0.21% 75
2024
Q4 		$351K Buy
+4,075
New +$441K 0.33% 47

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

WPG Advisers's NVO Position: Q2 2026 in Review

WPG Advisers increased its Novo Nordisk (NVO) stake by 280% in Q2 2026, buying an estimated $50.2K and bringing the position to 1,585 shares worth $76K. The position accounts for 0.04% of the portfolio, ranked #229.

WPG Advisers first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $351K in Q4 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • WPG Advisers held 1,585 shares of Novo Nordisk worth $76K as of Q2 2026.
  • WPG Advisers bought 1,168 Novo Nordisk shares in Q2 2026, an estimated $50.2K.
  • Novo Nordisk made up 0.04% of WPG Advisers's portfolio in Q2 2026, its #229 holding.
  • WPG Advisers first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Novo Nordisk position peaked at $351K in Q4 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.